(Q30398382)

English

The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

0 references

10

object named as

Itamar Grotto

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1

object named as

Dan Engelhard

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

5

object named as

Diana Averbuch

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Nurith Strauss-Liviatan

9

object named as

Nurith Strauss-Liviatan

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

11

object named as

Dana G Wolf

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Zichria Zakay-Rones

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Michael Y Shapira

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Igor Resnick

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sigal Grisariu

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Lillian Dray

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Esther Djian

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Reuven Or

12

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

7 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1777-1782

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Influenza A in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Respiratory virus infections in stem cell transplant patients: the European experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients After Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Vaccination of hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Revaccination with Measles, Tetanus, Poliovirus, Haemophilus influenzae Type B, Meningococcus C, and Pneumococcus Vaccines in Children after Hematopoietic Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.113

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.12.113

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30398382&oldid=1988449004"